195 related articles for article (PubMed ID: 17427383)
1. Distinguishing cardiac and noncardiac dyspnea in 48 dogs using plasma atrial natriuretic factor, B-type natriuretic factor, endothelin, and cardiac troponin-I.
Prosek R; Sisson DD; Oyama MA; Solter PF
J Vet Intern Med; 2007; 21(2):238-42. PubMed ID: 17427383
[TBL] [Abstract][Full Text] [Related]
2. Relationship of plasma N-terminal pro-brain natriuretic peptide concentrations to heart failure classification and cause of respiratory distress in dogs using a 2nd generation ELISA assay.
Fox PR; Oyama MA; Hezzell MJ; Rush JE; Nguyenba TP; DeFrancesco TC; Lehmkuhl LB; Kellihan HB; Bulmer B; Gordon SG; Cunningham SM; MacGregor J; Stepien RL; Lefbom B; Adin D; Lamb K
J Vet Intern Med; 2015 Jan; 29(1):171-9. PubMed ID: 25308881
[TBL] [Abstract][Full Text] [Related]
3. Prospective clinical evaluation of an ELISA B-type natriuretic peptide assay in the diagnosis of congestive heart failure in dogs presenting with cough or dyspnea.
DeFrancesco TC; Rush JE; Rozanski EA; Hansen BD; Keene BW; Moore DT; Atkins CE
J Vet Intern Med; 2007; 21(2):243-50. PubMed ID: 17427384
[TBL] [Abstract][Full Text] [Related]
4. Assessment of plasma cardiac troponin I concentration as a means to differentiate cardiac and noncardiac causes of dyspnea in cats.
Herndon WE; Rishniw M; Schrope D; Sammarco CD; Boddy KN; Sleeper MM
J Am Vet Med Assoc; 2008 Oct; 233(8):1261-4. PubMed ID: 18922052
[TBL] [Abstract][Full Text] [Related]
5. Comparison of N-terminal pro-atrial natriuretic peptide and three cardiac biomarkers for discriminatory ability of clinical stage in dogs with myxomatous mitral valve disease.
Ogawa M; Hori Y; Kanno N; Iwasa N; Toyofuku T; Isayama N; Yoshikawa A; Akabane R; Sakatani A; Miyakawa H; Hsu HH; Miyagawa Y; Takemura N
J Vet Med Sci; 2021 Apr; 83(4):705-715. PubMed ID: 33551383
[TBL] [Abstract][Full Text] [Related]
6. Prospective screening for occult cardiomyopathy in dogs by measurement of plasma atrial natriuretic peptide, B-type natriuretic peptide, and cardiac troponin-I concentrations.
Oyama MA; Sisson DD; Solter PF
Am J Vet Res; 2007 Jan; 68(1):42-7. PubMed ID: 17199417
[TBL] [Abstract][Full Text] [Related]
7. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea.
Harrison A; Morrison LK; Krishnaswamy P; Kazanegra R; Clopton P; Dao Q; Hlavin P; Maisel AS
Ann Emerg Med; 2002 Feb; 39(2):131-8. PubMed ID: 11823766
[TBL] [Abstract][Full Text] [Related]
8. NT-proBNP, NT-proANP and cTnI concentrations in dogs with pre-capillary pulmonary hypertension.
Kellihan HB; Mackie BA; Stepien RL
J Vet Cardiol; 2011 Sep; 13(3):171-82. PubMed ID: 21835711
[TBL] [Abstract][Full Text] [Related]
9. Midregional pro-atrial natriuretic peptide for the diagnosis of cardiac-related dyspnea according to renal function in the emergency department: a comparison with B-type natriuretic peptide (BNP) and N-terminal proBNP.
Chenevier-Gobeaux C; Guerin S; André S; Ray P; Cynober L; Gestin S; Pourriat JL; Claessens YE
Clin Chem; 2010 Nov; 56(11):1708-17. PubMed ID: 20813917
[TBL] [Abstract][Full Text] [Related]
10. Assessment of a point-of-care cardiac troponin I test to differentiate cardiac from noncardiac causes of respiratory distress in dogs.
Payne EE; Roberts BK; Schroeder N; Burk RL; Schermerhorn T
J Vet Emerg Crit Care (San Antonio); 2011 Jun; 21(3):217-25. PubMed ID: 21631707
[TBL] [Abstract][Full Text] [Related]
11. The effect of noncardiac disease on plasma brain natriuretic peptide concentration in dogs.
Lee JA; Herndon WE; Rishniw M
J Vet Emerg Crit Care (San Antonio); 2011 Feb; 21(1):5-12. PubMed ID: 21288288
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of blood cardiac troponin I concentrations obtained with a cage-side analyzer to differentiate cats with cardiac and noncardiac causes of dyspnea.
Wells SM; Shofer FS; Walters PC; Stamoulis ME; Cole SG; Sleeper MM
J Am Vet Med Assoc; 2014 Feb; 244(4):425-30. PubMed ID: 24479456
[TBL] [Abstract][Full Text] [Related]
13. Focused cardiac ultrasound and point-of-care NT-proBNP assay in the emergency room for differentiation of cardiac and noncardiac causes of respiratory distress in cats.
Janson CO; Hezzell MJ; Oyama MA; Harries B; Drobatz KJ; Reineke EL
J Vet Emerg Crit Care (San Antonio); 2020 Jul; 30(4):376-383. PubMed ID: 32579274
[TBL] [Abstract][Full Text] [Related]
14. Plasma atrial natriuretic peptide and N-terminal pro B-type natriuretic peptide concentrations in dogs with right-sided congestive heart failure.
Kanno N; Hori Y; Hidaka Y; Chikazawa S; Kanai K; Hoshi F; Itoh N
J Vet Med Sci; 2016 May; 78(4):535-42. PubMed ID: 26607133
[TBL] [Abstract][Full Text] [Related]
15. Circulating natriuretic peptides in cats with heart disease.
Connolly DJ; Magalhaes RJ; Syme HM; Boswood A; Fuentes VL; Chu L; Metcalf M
J Vet Intern Med; 2008; 22(1):96-105. PubMed ID: 18289295
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic relevance of NT-proBNP and proANP 31-67 measurements in staging of myxomatous mitral valve disease in dogs.
Wolf J; Gerlach N; Weber K; Klima A; Wess G
Vet Clin Pathol; 2013 Jun; 42(2):196-206. PubMed ID: 23614733
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the diagnostic accuracy of circulating natriuretic peptide concentrations to distinguish between cats with cardiac and non-cardiac causes of respiratory distress.
Connolly DJ; Soares Magalhaes RJ; Fuentes VL; Boswood A; Cole G; Boag A; Syme HM
J Vet Cardiol; 2009 May; 11 Suppl 1():S41-50. PubMed ID: 19394286
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers for differentiation of causes of respiratory distress in dogs and cats: Part 1--Cardiac diseases and pulmonary hypertension.
Smith KF; Quinn RL; Rahilly LJ
J Vet Emerg Crit Care (San Antonio); 2015; 25(3):311-29. PubMed ID: 26040814
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of plasma N-terminal pro-B-type natriuretic peptide concentrations in dogs with and without cardiac disease.
Ettinger SJ; Farace G; Forney SD; Frye M; Beardow A
J Am Vet Med Assoc; 2012 Jan; 240(2):171-80. PubMed ID: 22217025
[TBL] [Abstract][Full Text] [Related]
20. NT-proANP and BNP in renovascular and in severe and mild essential hypertension.
Mussalo H; Vanninen E; Ikäheimo R; Hartikainen J
Kidney Blood Press Res; 2003; 26(1):34-41. PubMed ID: 12697975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
